Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Estonia France Germany Greece +7
  • Study on the Effectiveness and Safety of Crovalimab vs. Eculizumab for Adults and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated with Complement Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Lithuania The Netherlands Poland Portugal +3
  • Study on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Czechia France Greece Italy Poland Spain
  • Study on the Effectiveness and Safety of Iptacopan for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH) Switching from Anti-C5 Antibody Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain
  • Study on Ravulizumab for Children with Paroxysmal Nocturnal Hemoglobinuria or Atypical Hemolytic Uremic Syndrome

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Italy Spain